[Federal Register Volume 66, Number 56 (Thursday, March 22, 2001)]
[Notices]
[Pages 16059-16060]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-7080]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-01-27]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

Proposed Project

    An Assessment of the Feasibility and Need for Support of Cervical 
Cancer Screening Services in Publicly Funded Sexually Transmitted 
Disease (STD) Clinics--New--National Center for Chronic Disease 
Prevention and Health Promotion (NCCDPHP), Centers for Disease Control 
Prevention (CDC).
    The National Center for Chronic Disease Prevention and Health 
Promotion, Division of Cancer Prevention and Control (DCPC) in 
collaboration with the National Center for HIV, STD, and TB Prevention, 
Division of STD Prevention proposes to evaluate the need for and 
suitability of delivering cervical cancer screening services to women 
receiving health care in public STD clinics. STD clinics provide health 
services to a population of women considered to be at high risk for 
human papillomavirus (HPV) infection. Certain HPV types cause abnormal 
Pap smears and are etiologically linked to cervical cancer. Many women 
who seek medical attention from STD clinics have limited access to 
other sources of health care. Moreover, there is limited published 
information about the cervical cancer screening behaviors or magnitude 
of cervical dysplasia in this at-risk population. CDC is conducting 
this project in response to a Congressional mandate encouraging the 
exploration of alternative strategies and methods to increase access to 
cervical cancer screening services among medically underserved women.
    To determine if STD clinics are an appropriate venue to identify 
women in need of cervical cancer screening services, DCPC will recruit 
and enroll a projected sample of 22,680 women attendees of eight 
publicly funded clinics. Four of the participating clinics will offer 
cervical cancer screening services and four will not provide these 
services. To estimate the need for cervical cancer screening among STD 
clinic attendees, women who meet the project enrollment criteria at all 
participating clinics will be asked to participate in a brief interview 
regarding their recent cervical cancer screening history and their need 
for screening.
    For women attending publicly funded STD clinics offering cervical 
cancer screening services, data will be collected on the results of the 
screening examination, results of the diagnostic assessments of 
abnormal screening tests, and the costs associated with cervical cancer 
screening and follow-up. For women attending clinics not offering 
cervical cancer screening, attendees determined to be in need of 
screening will be referred to local providers offering these services.
    A sub-study, verifying attendees reports of recent cervical 
screening services will be conducted on a sample of clinic attendees. 
Official Pap smear reports will be collected for those women who 
indicate a Pap smear was performed during the preceding 12 months. 
Clinic staff and health care provider activities will involve 
interviewing attendees, determining attendees eligibility status, and 
verifying Pap test results. The total costs to respondents will be 
$12,929.

----------------------------------------------------------------------------------------------------------------
                                                                    No. of       Average burden
                 Respondents                       No. of       responses per     per response     Total burden
                                                respondents       respondent        (in hrs)        (in hrs) 1
----------------------------------------------------------------------------------------------------------------
STD clinic--study enrollees.................           18,144                1            10/60            3,024
STD clinic staff............................           12,600                1             5/60            1,050
Health Care Providers.......................            7,742                1            10/60            1,290
                                             -------------------------------------------------------------------
      Total.................................  ...............  ...............  ...............           5,364
----------------------------------------------------------------------------------------------------------------
1 Estimates are based on a 12-month data collection period.



[[Page 16060]]

    Dated: March 15, 2001.
Nancy Cheal,
Acting Associate Director for Policy, Planning and Evaluation Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 01-7080 Filed 3-21-01; 8:45 am]
BILLING CODE 4163-18-P